Abstract
This study was designed to investigate whether mimecan was involved in aortic hypertrophy induced by sinoaortic denervation in rats. 8 weeks after sinoaortic denervation, when compared to sham-operated rats, sinoaortic denervated rats exhibited aortic hypertrophy and down-regulation of mimecan. Through classic univariate correlation analysis, it was found that mimecan mRNA was negatively related to extent of aortic hypertrophy. Treatment of primary cultured vascular smooth muscle cells with the Ang II (1 μM), which was found locally increased in the aortae of sinoaortic denervated rats, resulted in a reduction of mimecan expression. In vitro, knockdown of mimecan in vascular smooth muscle cells promoted cell proliferation induced by 15% of fetal bovine serum or Ang II (1 μM). We concluded that down-regulation of mimecan was involved in aortic hypertrophy induced by sinoaortic denervation in rats.
Similar content being viewed by others
References
Su DF, Miao CY (2001) Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol 28:709–715
Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G (1987) Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens 5:93–98
Sega R, Corrao G, Bombelli M, Beltrame L, Facchetti R, Grassi G, Ferrario M, Mancia G (2002) Blood pressure variability and organ damage in a general population: Results from the PAMELA study (Pressioni Arteriose Monitorate E Loro Associazioni). Hypertension 39:710–714
Lacolley P, Bezie Y, Girerd X, Challande P, Benetos A, Boutouyrie P, Ghodsi N, Lucet B, Azoui R, Laurent S (1995) Aortic distensibility and structural changes in sinoaortic-denervated rats. Hypertension 26:337–340
Miao CY, Tao X, Gong K, Zhang SH, Chu ZX, Su DF (2001) Arterial remodeling in chronic sinoaortic-denervated rats. J Cardiovasc Pharmacol 37:6–15
Cai GJ, Miao CY, Xie HH, Lu LH, Su DF (2005) Arterial baroreflex dysfunction promotes atherosclerosis in rats. Atherosclerosis 183:41–47
Shen FM, Zhang SH, Xie HH, Jing Q, Wang DS, Su DF (2006) Early structure changes of aortic wall in sinoaortic denervated rats. Clin Exp Pharmacol Physiol 33:358–363
Madisen L, Neubauer M, Plowman G, Rosen D, Segarini P, Dasch J, Thompson A, Ziman J, Bentz H, Purchio AF (1990) Molecular cloning of a novel bone-forming compound: osteoinductive factor. DNA Cell Biol 9:303–309
Funderburgh JL, Corpuz LM, Roth MR, Funderburgh ML, Tasheva ES, Conrad GW (1997) Mimecan, the 25-kDa corneal keratan sulfate proteoglycan, is a product of the gene producing osteoglycin. J Biol Chem 272:28089–28095
Ujita M, Shinomura T, Kimata K (1995) Molecular cloning of the mouse osteoglycin-encoding gene. Gene 158:237–240
Tasheva ES, Funderburgh ML, McReynolds J, Funderburgh JL, Conrad GW (1999) The bovine mimecan gene. Molecular cloning and characterization of two major RNA transcripts generated by alternative use of two splice acceptor sites in the third exon. J Biol Chem 274:18693–18701
Tasheva ES, Corpuz LM, Funderburgh JL, Conrad GW (1997) Differential splicing and alternative polyadenylation generate multiple mimecan mRNA transcripts. J Biol Chem 272:32551–32556
Tasheva ES, Pettenati M, Von Kap-Her C, Conrad GW (2000) Assignment of mimecan gene (OGN) to human chromosome band 9q22 by in situ hybridization. Cytogenet Cell Genet 88:326–327
Csordas G, Santra M, Reed CC, Eichstetter I, McQuillan DJ, Gross D, Nugent MA, Hajnóczky G, Iozzo RV (2000) Sustained downregulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo. J Biol Chem 275:32879–32887
Iozzo R (1997) The family of small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 32:141–174
Zimmermann R, Kampmann A, Kubin T (2004) Differential expression of the extracellular matrix (ECM) components mimecan and elastin during arteriogenesis. J Mol Cell Cardiol 37:170
Li L, Yi-Ming W, Li ZZ, Zhao L, Yu YS, Li DJ, Xia CY, Liu JG, Su DF (2008) Local RAS and inflammatory factors are involved in cardiovascular hypertrophy in spontaneously hypertensive rats. Pharmacol Res 58(3–4):196–201
Miao CY, Xie HH, Wang JJ, Su DF (2002) Candesartan inhibits sinoaortic denervation-induced cardiovascular hypertrophy in rats. Acta Phamacol Sin 23:713–720
Ishida M, Ishida T, Thomas S, Berk BC (1998) Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 82:7–12
Ishida T, Ishida M, Suero J, Takahashi M, Berk BC (1999) Agonist-stimulated cytoskeletal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 103:789–797
Shen FM, Zhu GM, Miao CY, Guan YF, Su DF (2004) ATP-sensitive potassium channels are involved in adenosine-induced reduction of blood pressure variability in spontaneously hypertensive rats. J Cardiovasc Pharmacol 44:87–92
Liu JG, Xu LP, Chu ZX, Miao CY, Su DF (2003) Contribution of blood pressure variability to the effect of nitrendipine on end-organ damage in spontaneously hypertensive rats. J Hypertens 21:1961–1967
Fu YJ, Shu H, Miao CY, Wang MW, Su DF (2004) Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens 22:1165–1172
Frattola A, Parati G, Cuspidi C, Albini F, Mancia G (1993) Prognostic value of 24-hour blood pressure variability. J Hypertens 11:1133–1137
Miao CY, Su DF (2002) The importance of blood pressure variability in rat aortic and ventricular hypertrophy produced by sinoaortic denervation. J Hypertens 20:1865–1872
Bentz H, Nathan RM, Rosen DM, Armstrong RM, Thompson AY, Segarini PR, Mathews MC, Dasch JR, Piez KA, Seyedin SM (1989) Purification and characterization of a unique osteoinductive factor from bovine bone. J Biol Chem 264:20805–20810
Bentz H, Thompson AY, Armstrong R, Chang RJ, Piez KA, Rosen DM (1991) Transforming growth factor-β2 enhances the osteoinductive activity of a bovine bone-derived fraction containing bone morphogenetic protein-2 and -3. Matrix 11:269–275
Andreas K, Borja K, Elisabeth D, Thomas K, Frederic P, Inka E, Imo EH, Wolfgang S, Zimmermann R (2009) The proteoglycan osteoglycin/mimecan is correlated with arteriogenesis. Mol Cell Biochem 322:15–23
Shanahan CM, Cary NR, Osboum JK, Weissberg PL (1997) Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in athemselemtic plaques. Arterioscler Thromb Vasc Biol 17(11):2437–2447
Fernandez B, Kampmann A, Pipp F, Zimmermann R, Schaper W (2003) Osteoglycin expression and localization in rabbit tissues and atherosclerotic plaques. Mol Cell Biochem 246(1):3–11
Borja F, Maria CF, Javier M, Ana CD, Miguel S, Valentin SC (2009) Absence of mimecan causes medial damage associated with atherosclerotic lesions in apoE-deficient mice. FASEB J 23:640.1
Acknowledgment
This study was supported by the Grant from the National Natural Science Foundation of China (No. 30700380).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gu, XS., Lei, JP., Shi, JB. et al. Mimecan is involved in aortic hypertrophy induced by sinoaortic denervation in rats. Mol Cell Biochem 352, 309–316 (2011). https://doi.org/10.1007/s11010-011-0767-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-0767-8